A Study Evaluating the Efficacy, Safety, and Tolerability of Ertapenem versus Ceftriaxone for the Treatment of Community‐Acquired Pneumonia in Adults
Authors:
- Ian R. FriedlandIFIan R. Friedland
- Protocol 018 Ertapenem Community-Acquired Pneumonia Study GroupPGProtocol 018 Ertapenem Community-Acquired Pneumonia Study Group
Open Access
- 15 April 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (8) , 1076-1083
Abstract
In a double-blind, multicenter trial, 502 patients hospitalized with community-acquired pneumonia were randomized to receive therapy with either ertaKeywords
This publication has 18 references indexed in Scilit:
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates [In Process Citation]Journal of Antimicrobial Chemotherapy, 1998
- Community‐Acquired Pneumonia in Adults: Guidelines for ManagementClinical Infectious Diseases, 1998
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysisJAMA, 1996
- Single daily dose of cefodizime in patients with community-acquired pneumonia: an open-label, controlled, randomized studyClinical Therapeutics, 1995
- Cefoperazone versus ceftriaxone monotherapy of nosocomial pneumoniaDiagnostic Microbiology and Infectious Disease, 1992
- Comparative Efficacy of Ceftriaxone versus Ceftazidime in the Treatment of Nosocomial Lower Respiratory Tract InfectionsChemotherapy, 1991
- “Proving the null hypothesis” in clinical trialsControlled Clinical Trials, 1982
- Some Methods for Strengthening the Common χ 2 TestsBiometrics, 1954